IXICO plc (IXI:LSE) Investor Relations Material

Overview

IXICO is a leading provider of neuroimaging services for biopharmaceutical companies. The company offers solutions that help these companies extract clinically relevant insights from their data to streamline drug development pipelines. With a team of experts in the field of neuroscience, innovative analytics tools, and operational efficiency, IXICO is a trusted partner for imaging biomarker solutions in clinical trials. The company's ability to bridge the gap between data and clinical meaning makes it an invaluable asset to the pharmaceutical industry.

Frequently Asked Questions

What is IXICO plc's ticker?

IXICO plc's ticker is IXI

What exchange is IXICO plc traded on?

The company's shares trade on the LSE stock exchange

Where are IXICO plc's headquarters?

They are based in London, England

How many employees does IXICO plc have?

There are 51-200 employees working at IXICO plc

What is IXICO plc's website?

It is https://ixico.com/

What type of sector is IXICO plc?

IXICO plc is in the Healthcare sector

What type of industry is IXICO plc?

IXICO plc is in the Biotechnology industry

Who are IXICO plc's peers and competitors?

The following five companies are IXICO plc's industry peers:

- Evofem Biosciences

- Jaguar Health

- ICON Public Company

- Genmab

- Intellia Therapeutics